186 related articles for article (PubMed ID: 21633700)
1. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.
Lengagne R; Pommier A; Caron J; Douguet L; Garcette M; Kato M; Avril MF; Abastado JP; Bercovici N; Lucas B; Prévost-Blondel A
PLoS One; 2011; 6(5):e20235. PubMed ID: 21633700
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
Pommier A; Audemard A; Durand A; Lengagne R; Delpoux A; Martin B; Douguet L; Le Campion A; Kato M; Avril MF; Auffray C; Lucas B; Prévost-Blondel A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13085-90. PubMed ID: 23878221
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.
Wang Z; Liu JQ; Liu Z; Shen R; Zhang G; Xu J; Basu S; Feng Y; Bai XF
J Immunol; 2013 Mar; 190(5):2415-23. PubMed ID: 23345334
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH
J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788
[TBL] [Abstract][Full Text] [Related]
6. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
[TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF.
Spear P; Barber A; Rynda-Apple A; Sentman CL
J Immunol; 2012 Jun; 188(12):6389-98. PubMed ID: 22586039
[TBL] [Abstract][Full Text] [Related]
9. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
Wallecha A; Singh R; Malinina I
J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
[TBL] [Abstract][Full Text] [Related]
10. IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours.
Wang LX; Talebian F; Liu JQ; Khattabi M; Yu L; Bai XF
Scand J Immunol; 2012 Mar; 75(3):273-81. PubMed ID: 22050574
[TBL] [Abstract][Full Text] [Related]
11. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
Kerkar SP; Goldszmid RS; Muranski P; Chinnasamy D; Yu Z; Reger RN; Leonardi AJ; Morgan RA; Wang E; Marincola FM; Trinchieri G; Rosenberg SA; Restifo NP
J Clin Invest; 2011 Dec; 121(12):4746-57. PubMed ID: 22056381
[TBL] [Abstract][Full Text] [Related]
12. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
[TBL] [Abstract][Full Text] [Related]
13. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation.
Umansky V; Sevko A
Cancer Immunol Immunother; 2012 Feb; 61(2):275-282. PubMed ID: 22120757
[TBL] [Abstract][Full Text] [Related]
14. Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.
Gros A; Turcotte S; Wunderlich JR; Ahmadzadeh M; Dudley ME; Rosenberg SA
Clin Cancer Res; 2012 Oct; 18(19):5212-23. PubMed ID: 22837179
[TBL] [Abstract][Full Text] [Related]
15. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
[TBL] [Abstract][Full Text] [Related]
16. Arginase-dependent suppression by CpG-ODN plus IFA-induced splenic myeloid CD11b(+)Gr1(+) cells.
Ranocchia RP; Gorlino CV; Crespo MI; Harman MF; Liscovsky MV; Morón G; Maletto BA; Pistoresi-Palencia MC
Immunol Cell Biol; 2012 Aug; 90(7):710-21. PubMed ID: 22083526
[TBL] [Abstract][Full Text] [Related]
17. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
18. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
Lengagne R; Graff-Dubois S; Garcette M; Renia L; Kato M; Guillet JG; Engelhard VH; Avril MF; Abastado JP; Prévost-Blondel A
J Immunol; 2008 Jan; 180(1):130-7. PubMed ID: 18097012
[TBL] [Abstract][Full Text] [Related]
19. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
[TBL] [Abstract][Full Text] [Related]
20. Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity.
Kaimala S; Mohamed YA; Nader N; Issac J; Elkord E; Chouaib S; Fernandez-Cabezudo MJ; Al-Ramadi BK
Cancer Immunol Immunother; 2014 Jun; 63(6):587-99. PubMed ID: 24668365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
